ASX:IPD ImpediMed (IPD) Stock Price, News & Analysis → Trump Reveals Conspiracy Behind Fed-Controlled Digital Currency. (From Monetary Gold) (Ad) Free IPD Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume1.62 million shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend Yield3.28%Price TargetN/A Stock AnalysisStock Analysis Get ImpediMed alerts: Email Address Ad Huge AlertsWhy Is Gold On a MASSIVE rally? Gold has been on a tear this year. The yellow metal has hit an all-time high of $2,4231.29 recently and the rally could be far from over. From central banks to even Costco customers, it seems everyone is buying gold these days. With Wall Street watching the gold space carefully, now is a perfect time to pay attention to this stock.This Little known Company is a uniquely structured for profit About ImpediMed Stock (ASX:IPD)ImpediMed Limited, a medical technology company, develops, manufactures, and sells bioimpedance spectroscopy (BIS) devices and software services in Australia, North America, and internationally. The company offers SOZO, a noninvasive BIS device for the assessment of lymphedema, and deliver snapshot of fluid status and tissue composition; SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. It sells its devices to hospitals and clinics. The company was incorporated in 1999 and is headquartered in Pinkenba, Australia.Read More Ad Huge AlertsWhy Is Gold On a MASSIVE rally? Gold has been on a tear this year. The yellow metal has hit an all-time high of $2,4231.29 recently and the rally could be far from over. From central banks to even Costco customers, it seems everyone is buying gold these days. With Wall Street watching the gold space carefully, now is a perfect time to pay attention to this stock.This Little known Company is a uniquely structured for profit IPD Stock News HeadlinesMarch 14, 2024 | finance.yahoo.comImpediMed's (ASX:IPD) investors will be pleased with their notable 72% return over the last yearMarch 11, 2024 | msn.comSkin in the game: Which ASX director is betting on a lithium recovery?February 26, 2024 | benzinga.comImpedimed Stock (OTC:IPDQF) Dividends: History, Yield and DatesFebruary 20, 2024 | msn.comHow the experts are investing in healthcare-related AI and biotechFebruary 16, 2024 | msn.comScoPo’s Powerplays: ASX health stocks tumble as CSL bleeds after Phase III trial misses endpointFebruary 3, 2024 | morningstar.comImpedimed Ltd IPDNovember 19, 2023 | msn.comMarket Highlights: Wall Street sentiment remains high, 9 most innovative firms, and 5 small caps to watch todayNovember 19, 2023 | fool.com.au2 ASX All Ords shares tumbling following leadership shakeupsNovember 3, 2023 | msn.comScoPo’s Powerplays: Who fancies 22 minutes of exercise? And ASX health stocks are up (finally)October 21, 2023 | afr.comImpediMed LimitedOctober 6, 2023 | finance.yahoo.comInvesting in ImpediMed (ASX:IPD) a year ago would have delivered you a 146% gainSeptember 1, 2023 | finance.yahoo.comAnalysts Expect Breakeven For ImpediMed Limited (ASX:IPD) Before LongAugust 29, 2023 | finance.yahoo.comThe IPD Group Limited (ASX:IPG) Annual Results Are Out And Analysts Have Published New ForecastsJuly 17, 2023 | finance.yahoo.comHere's Why We're Watching ImpediMed's (ASX:IPD) Cash Burn SituationJuly 13, 2023 | finance.yahoo.comIPD.AX - ImpediMed LimitedJuly 12, 2023 | au.finance.yahoo.comIPD.XA - ImpediMed LimitedJune 30, 2023 | msn.comScoPo’s (actually Wilkie’s) Powerplays: Inoviq soars on clinical data for breast cancer testMay 26, 2023 | msn.comScoPo’s Powerplays: ASX health stocks fall as investors fail to reward good newsApril 22, 2023 | msn.comWILSONS Maintains ImpediMed (ASX:IPD) Overweight RecommendationApril 21, 2023 | msn.comScoPo’s (actually Iain’s) Powerplays: ASX health stocks fall, Neuren’s DAYBUE drug officially rolling out in USApril 7, 2023 | finance.yahoo.comImpediMed (ASX:IPD) shareholders have earned a 40% CAGR over the last three yearsMarch 31, 2023 | msn.comScoPo’s Powerplays: ASX health stocks rise, ImpediMed surges 99% on NCCN guidelines updateMarch 27, 2023 | msn.comGuess which ASX biotech share just rocketed 86% on ‘a major validating moment’March 26, 2023 | msn.comASX Small Caps Lunch Wrap: Who else is having trouble believing their eyes this morning?March 26, 2023 | msn.comTop 10 at 10: Cancer fighters, new lithium leaders, and a lucrative takeover offerSee More Headlines Receive IPD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ImpediMed and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolASX:IPD CUSIPN/A CIKN/A Webwww.impedimed.com Phone61 7 3860 3700FaxN/AEmployees76Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E Growth-102.5Net Income$-19,500,000.00 Net Margins-185.47% Pretax MarginN/A Return on Equity-42.36% Return on Assets-27.58% Debt Debt-to-Equity Ratio2.50 Current Ratio7.00 Quick Ratio6.23 Sales & Book Value Annual Sales$10.47 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow1.60 Book ValueA$0.03 per share Price / BookN/AMiscellaneous Outstanding Shares2,020,000,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta2.93 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Key ExecutivesMr. Shashi TripathiChief Operating OfficerDr. Parmjot Bains M.D.MD, Interim CEO & DirectorMr. McGregor Grant BEcC.A., FCIS, GAICD, Interim CFO & Executive DirectorMr. Dennis SchlahtSenior Vice President of R&D and TechnologyLisa PromVice President of SalesMs. Joann YaoChief Strategy OfficerDr. Steven Chen M.B.A.M.D., Chief Medical CenterMs. Leanne Ralph AAICDACIS, BBus, Company SecretaryDr. Walton A. TaylorMedical DirectorMore ExecutivesKey Competitors4DMedicalASX:4DXAdheriumASX:ADRAinosNASDAQ:AIMDWAllegra Medical TechnologiesASX:AMTAnalyticaASX:ALTView All CompetitorsInsidersChristine Emmanuel-DonnellyBought 100,000 shares on 5/14/2024Total: $8,000.00 ($0.08/share)Janelle DelaneyBought 634,177 shares on 5/8/2024Total: $50,099.98 ($0.08/share)Andrew GrantBought 100,000 shares on 5/6/2024Total: $8,100.00 ($0.08/share)Janelle DelaneyBought 568,181 shares on 3/25/2024Total: $49,999.93 ($0.09/share)Janelle DelaneyBought 581,395 shares on 3/22/2024Total: $49,999.97 ($0.09/share) IPD Stock Analysis - Frequently Asked Questions What other stocks do shareholders of ImpediMed own? Based on aggregate information from My MarketBeat watchlists, some companies that other ImpediMed investors own include Bardoc Gold (BDC) and Appen (APX). This page (ASX:IPD) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldDems have chosen Biden replacement?Paradigm PressDoes this make you sick?Allegiance GoldHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportWhy Is Gold On a MASSIVE rally? Huge AlertsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingTrump Reveals Conspiracy Behind Fed-Controlled Digital Currency.Monetary GoldA ‘DeFi Summer’ Projected!Crypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ImpediMed Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.